Theseus Pharmaceuticals, Inc.

THRX · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$94,605$244,662$8,457$1,317
Short-Term Investments$103,374$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$4,137$3,309$113$64
Total Curr. Assets$197,979$247,971$8,570$1,381
Property Plant & Equip (Net)$4,750$11$1$3
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$13,817$379$0$0
Tax Assets$0$0$0$0
Other NC Assets$5,901$2,568$43$43
Total NC Assets$24,468$2,958$44$46
Other Assets$0$0$0$0
Total Assets$222,447$250,929$8,614$1,427
Liabilities
Payables$4,973$1,002$1,132$285
Short-Term Debt$743$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$5,414$2,678$463$330
Total Curr. Liab.$11,130$3,680$1,595$615
LT Debt$3,236$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$466$815$41,289$10,219
Total NC Liab.$3,702$815$41,289$10,219
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$14,832$4,495$42,884$10,834
Equity
Pref Stock$0$250,929$0$0
Common Stock$4$4$0$0
Retained Earnings-$112,186-$61,578-$34,270-$10,220
AOCI-$386-$250,929$0$813
Other Equity$320,183$308,008$0-$6,044
Total Equity$207,615$246,434-$34,270-$9,407
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$222,447$250,929$8,614$1,427
Net Debt-$90,626-$244,662-$8,457-$1,317